Investing.com - Abbott Labs (NYSE:ABT) reported fourth quarter earnings that matched analysts' expectations on Wednesday and revenue that topped forecasts.
The firm reported earnings per share of $0.95 on revenue of $8.31B. Analysts polled by Investing.com expected EPS of $0.95 on revenue of $8.26B. That compared to EPS of $0.81 on revenue of $7.77B in the same period a year earlier. The company had reported EPS of $0.84 on revenue of $8.08B in the previous quarter.
Abbott Labs shares gained 0.59% to trade at $90.26 in pre-market trade following the report.
For the year, Abbott Labs shares are up 3.3%, outperforming the S&P 500 which is up 2.33% year to date.
Abbott Labs follows other major Healthcare sector earnings this month
On Wednesday, J&J reported fourth quarter EPS of $1.88 on revenue of $20.75B, compared to forecasts of EPS of $1.87 on revenue of $20.78B.
Novocure Ltd earnings beat analyst's expectations on October 31, 2019, with third quarter EPS of $0.02 on revenue of $92.06M. Investing.com analysts expected EPS of $-0.04 on revenue of $86.94M
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar